TYSONS CORNER, VA, Feb. 8, 2018 — Booz Allen Hamilton (NYSE: BAH) has secured a position under a potential $300 million blanket purchase agreement with the Food and Drug Administration for data collection and analysis services, GovCon Wire reported Wednesday.
The Washington Business Journal reported Wednesday Booz Allen and Octo Consulting Group, the other awardee, will provide the services in support of FDA’s drug development and patient safety programs at the Center for Drug Evaluation and Research.
About Executive Mosaic: Founded in 2002, Executive Mosaic is a leadership organization and media company. Executive Mosaic offers highly coveted executive events, breaking business news on the Government Contracting industry, and delivers robust and reliable content through seven influential websites and four consequential E-newswires. Headquarters are located in Tysons Corner, VA. www.executivemosaic.com